Agilent Technologies, Inc. (NYSE:A) Position Increased by Noesis Capital Mangement Corp

Noesis Capital Mangement Corp increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,689 shares of the medical research company’s stock after acquiring an additional 3,382 shares during the period. Agilent Technologies comprises approximately 3.0% of Noesis Capital Mangement Corp’s portfolio, making the stock its 11th biggest holding. Noesis Capital Mangement Corp’s holdings in Agilent Technologies were worth $15,945,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. CKW Financial Group increased its position in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares during the last quarter. Global X Japan Co. Ltd. increased its position in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after buying an additional 116 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Agilent Technologies during the third quarter worth $31,000. Hanson & Doremus Investment Management increased its position in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new position in Agilent Technologies during the third quarter worth $38,000.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research report on Monday, December 9th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Robert W. Baird lowered their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday. Bank of America lowered their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Finally, Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Stock Up 0.6 %

A stock opened at $127.83 on Friday. Agilent Technologies, Inc. has a twelve month low of $124.16 and a twelve month high of $155.35. The company has a market cap of $36.47 billion, a PE ratio of 29.39, a price-to-earnings-growth ratio of 3.44 and a beta of 1.07. The business’s 50-day simple moving average is $140.64 and its 200 day simple moving average is $139.14. The company has a quick ratio of 1.58, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is 22.76%.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.